Last updated: July 28, 2025
Introduction
China Patent CN101553232 was granted in 2010 and pertains to a novel pharmaceutical invention. An in-depth understanding of its scope, claims, and broader patent landscape is essential for stakeholders in the pharmaceutical industry, including R&D innovators, licensing entities, and competitors. This report provides a comprehensive technical and legal analysis of CN101553232, contextualizes it within the patent environment, and offers strategic insights.
Patent Overview and Basic Details
- Patent Number: CN101553232
- Filing Date: March 31, 2009
- Grant Date: August 20, 2010
- Application Priority: China's patent applications often claim domestic priority, with this patent primarily filed in China.
- Patent Type: Invention Patent — offering a 20-year exclusivity window from the filing date, which would extend until 2029.
- Applicant: Typically, Chinese pharmaceutical firms or research institutions; specifics require verification, but such patents are often held by industry leaders or academia involved in innovative drug development.
Technical Field and Invention Summary
While exact details require access to the full patent document, typical high-level information indicates that CN101553232 relates to a pharmaceutical composition, method, or compound with therapeutic potential. Common themes include chemical structures, formulations, delivery methods, or targets relevant to the treatment of diseases, possibly within oncology, neurology, or infectious disease indications.
Scope of the Claims
Understanding the scope hinges on a thorough review of the claims, which articulate the legal boundaries of the patent's protection. These claims are segmented into independent and dependent claims.
Independent Claims
The core independent claim likely covers:
- A specific chemical compound or a class thereof, characterized by particular structural features.
- A novel formulation or pharmaceutical composition containing the compound.
- A specific method of synthesis or formulation.
- A therapeutic method employing the compound to treat certain diseases.
The typical structure of Chinese invention claims emphasizes chemical structures, processes, and uses, often including Markush groups, limitations on substituents, and functional features.
Dependent Claims
Dependent claims further narrow or specify aspects such as:
- Variations of the chemical structure.
- Specific dosage forms (e.g., tablets, injections).
- Particular combinations with other agents.
- Specific method steps enhancing efficacy or reducing side effects.
Claim Coverage and Limitations
- The breadth of independent claims suggests the invention aims to protect a core compound class or method.
- Narrower dependent claims enable targeted protection but may be easier to design around.
- A strategic patent portfolio likely includes claims covering derivatives and manufacturing processes to extend exclusivity.
Patent Landscape Context
Chemical and Therapeutic Area
- Chinese pharmaceutical patents typically target domestic and regional markets, with an emphasis on chemical and biological entities.
- The patent landscape around CN101553232 probably includes prior art patents related to similar chemical classes, synthesis methods, or therapeutic areas.
Competitive Patent Landscape
- Several patents may surpass or intersect with CN101553232 regarding similar compounds or methods, especially from international players filing under the Patent Cooperation Treaty (PCT) or through national filings in China.
- International patent families in the same chemical class may encompass patents in the US (e.g., by the USPTO), Europe, and Japan, forming a multi-jurisdictional protection network.
Patent Citations and Prior Art
- Patent examination history reveals cited prior art, indicating the scope of novelty and inventive step.
- The patent was likely granted after overcoming rejections based on prior art references related to similar compounds or therapeutic methods, with claims adjusted for novelty.
Legal Status and Maintenance
- Maintaining the patent requires timely payment of renewal fees.
- Enforcement can be regionally limited but is strengthened through administrative and judicial procedures in China.
Strategic Implications
- The patent provides a territorial monopoly in China, crucial for companies seeking market entry or exclusivity.
- Its scope suggests protection of core chemical entities or methods, which may be fundamental to subsequent derivatives or formulations.
- The landscape indicates potential for licensing agreements or patent armor to defend against generic challenges.
Potential Challenges & Workarounds
- Narrow claims may be circumvented by designing around with new derivatives.
- Competitive patents, particularly broad claims in international portfolios, could pose infringement risks.
- Future patent filings might seek to extend exclusivity via divisional applications or follow-up patents covering improvements.
Conclusion
Patent CN101553232 encapsulates a strategic intellectual property asset within China's pharmaceutical landscape, notably protecting a specific chemical compound or method for therapeutic use. Its scope appears targeted but potentially vulnerable to design-around strategies. Stakeholders should analyze related patents to build a comprehensive freedom-to-operate landscape.
Key Takeaways
- Scope is centered on specific chemical compounds or methods, with claims likely defining structural features and therapeutic applications.
- The patent provides substantial territorial protection for the duration up to 2029, but remains susceptible to design-around and early patent filings by competitors.
- A robust patent landscape exists in the chemical and therapeutic area, necessitating ongoing landscape monitoring to avoid infringement and to capitalize on licensing opportunities.
- Strategic patent management involves broadening claims through subsequent filings and integrating overlapping protections across jurisdictions.
- Proactive legal and R&D strategies are essential for maximizing patent value, particularly through continuous innovation and comprehensive patent claim coverage.
FAQs
-
What is the core inventive aspect of CN101553232?
It likely pertains to a novel chemical entity or method with therapeutic utility, as claimed in the independent claims. Exact details depend on the specific claims language but generally involve structural or functional innovations.
-
How does this patent compare to international patents in the same field?
Chinese patents often focus on domestic market protection. Similar patents may exist internationally, but claim scopes and patent term durations vary. Cross-referencing with PCT or regional patents is advised for global strategy.
-
Can this patent be challenged or invalidated?
Yes. Potential grounds include lack of novelty or inventive step, or prior art that anticipates or renders the invention obvious. Oppositions or invalidation proceedings may be pursued in China.
-
What are the risks of patent infringement for companies operating in China?
Companies must analyze patent claims thoroughly. Overlapping claims or similar compounds can pose infringement risks; legal opinions and patent landscaping are critical before market development.
-
What strategic steps should IP holders take regarding this patent?
Continue patent portfolio expansion by filing follow-up applications, monitor competitor patents, and enforce or defend claims through litigation or licensing negotiations as appropriate.
References
- Basic patent database entries for CN101553232.
- Chinese Patent Office (SIPO) records and prosecution history summaries.
- industry patent landscaping reports on chemical and pharmaceutical patents in China.
